Oncopeptides AB (publ)

Stockholm Stock Exchange ONCO.ST

Oncopeptides AB (publ) Share Price on January 14, 2025: USD 0.12

Oncopeptides AB (publ) Share Price is USD 0.12 on January 14, 2025, a -74.57% change year over year. Share price reflects current trading price of a company's stock; influenced by market dynamics and company performance.

Oncopeptides AB (publ) 52-week high Share Price is USD 0.52 on February 22, 2024, which is 334.05% above the current Share Price.
Oncopeptides AB (publ) 52-week low Share Price is USD 0.12 on January 14, 2025, which is 0.00% below the current Share Price.
Oncopeptides AB (publ) average Share Price for the last 52 weeks is USD 0.27.

Key data

Date	Share Price	Price to Earnings Ratio (P/E)	Price to Sales Ratio (P/S)	Price to Book Ratio (P/B)

Stockholm Stock Exchange: ONCO.ST

Oncopeptides AB (publ)

CEO	Ms. Sofia Heigis M.Sc.
IPO Date	Feb. 22, 2017
Location	Sweden
Headquarters	Vastra Tradgardsgatan 15
Employees	79
Sector	Health Care
Industries Pharmaceuticals Biotechnology

Description

Oncopeptides AB (publ), a biotech company, develops pharmaceuticals drugs for the treatment of cancer in the United States, Europe, and internationally. Its lead product candidate is melflufen, an anti-cancer peptide drug conjugate for the treatment of relapsed refractory multiple myeloma in adult patients. Oncopeptides AB (publ) was incorporated in 2000 and is headquartered in Stockholm, Sweden.

Key trends

Past 5 years